E-LIB Suche - Ergebnisse für: GEIGER, MARY JANE

1

Restricted mean survival time for the analysis of cardiovas..:

Manner, David H. ; Battioui, Chakib ; Hantel, Stefan...
American Heart Journal. 215 (2019) - p. 178-186 , 2019

Link: https://doi.org/10.1016/..

2

ODYSSEY FH I and FH II: 78 week results with alirocumab tre..:

Kastelein, John J.P. ; Ginsberg, Henry N. ; Langslet, Gisle...
European Heart Journal. , 2015

Link: https://doi.org/10.1093/..

3

Centralized adjudication of cardiovascular end points in ca..:

Seltzer, Jonathan H. ; Turner, J. Rick ; Geiger, Mary Jane...
American Heart Journal. 169 (2015) 2 - p. 197-204 , 2015

Link: https://doi.org/10.1016/..

4

Clinical Development Approaches and Statistical Methodologi..:

Geiger, Mary Jane ; Mehta, Cyrus ; Turner, J. Rick...
Therapeutic Innovation & Regulatory Science. 49 (2015) 1 - p. 50-64 , 2015

Link: https://doi.org/10.1177/..

5

The evaluation and management of drug effects on cardiac co..:

Nada, Adel ; Gintant, Gary A. ; Kleiman, Robert...
American Heart Journal. 165 (2013) 4 - p. 489-500 , 2013

Link: https://doi.org/10.1016/..

6

Operational Challenges and Solutions with Implementation of..:

Spencer, Kimberly ; Colvin, Kelly ; Braunecker, Brad...
Journal of Diabetes Science and Technology. 6 (2012) 6 - p. 1296-1304 , 2012

Link: https://doi.org/10.1177/..

7

An Adaptive, Dose-Finding, Seamless Phase 2/3 Study of a Lo..:

Geiger, Mary Jane ; Skrivanek, Zachary ; Gaydos, Brenda...
Journal of Diabetes Science and Technology. 6 (2012) 6 - p. 1319-1327 , 2012

Link: https://doi.org/10.1177/..

8

Application of Adaptive Design Methodology in Development o..:

Skrivanek, Zachary ; Berry, Scott ; Berry, Don...
Journal of Diabetes Science and Technology. 6 (2012) 6 - p. 1305-1318 , 2012

Link: https://doi.org/10.1177/..

9

Electrocardiographic assessment for therapeutic proteins—sc..:

Rodriguez, Ignacio ; Erdman, Andrew ; Padhi, Desmond...
American Heart Journal. 160 (2010) 4 - p. 627-634 , 2010

Link: https://doi.org/10.1016/..

10

Effect of Raloxifene on Cardiovascular Adverse Events in Po..:

Ensrud, Kristine ; Riccardo Genazzani, Andrea ; Geiger, Mary Jane...
The American Journal of Cardiology. 97 (2006) 4 - p. 520-527 , 2006

Link: https://doi.org/10.1016/..

11

Baseline characteristics of menopausal women with coronary ..:

Wenger, Nanette K. ; Geiger, Mary Jane
Contemporary Clinical Trials. 26 (2005) 6 - p. 612-615 , 2005

Link: https://doi.org/10.1016/..

12

Relationship Between Osteoporosis and Cardiovascular Diseas..:

Tankó, László B ; Christiansen, Claus ; Cox, David A...
Journal of Bone and Mineral Research. 20 (2005) 11 - p. 1912-1920 , 2005

Link: https://doi.org/10.1359/..

13

Risk-Benefit Profile for Raloxifene: 4-Year Data From the M..:

Barrett-Connor, Elizabeth ; Cauley, Jane A ; Kulkarni, Pandurang M...
Journal of Bone and Mineral Research. 19 (2004) 8 - p. 1270-1275 , 2004

Link: https://doi.org/10.1359/..

14

Safety of Slow Pathway Ablation in Patients with Long PR In..:

NATALE, ANDREA ; GREENFIELD, RUTH ANN ; GEIGER, MARY JANE...
Pacing and Clinical Electrophysiology. 20 (1997) 6 - p. 1698-1703 , 1997

Link: https://doi.org/10.1111/..

15

Right Side Implant of the Unipolar Single Lead Defihrillati..:

NATALE, ANDREA ; SRA, JASBIR ; GEIGER, MARY JANE...
Pacing and Clinical Electrophysiology. 20 (1997) 8 - p. 1910-1912 , 1997

Link: https://doi.org/10.1111/..